AVDL insider transactions
Avadel Pharmaceuticals plc (AVDL) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for AVDL
- Former 10% Owner Weiss Asset Management Lp sold $233,353,092 worth of Ordinary Shares (11,112,052 units at $21.00) (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- New insider Weiss Asset Management Lp claimed ownership of 11,112,052 units of Ordinary Shares (SEC Form 3)3 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- SEC Form 4 filed by Chief Operating Officer Rodriguez Susan4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- Director Thornton Peter J. returned $2,416,260 worth of Ordinary Shares to the company (115,060 units at $21.00), closing all direct ownership in the company (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- Gen. Counsel & Corp. Secretary Seurer Jerad G. returned $493,416 worth of Ordinary Shares to the company (23,496 units at $21.00), closing all direct ownership in the company (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- Director Palczuk Linda returned $1,657,005 worth of Ordinary Shares to the company (78,905 units at $21.00), closing all direct ownership in the company (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- Chief Financial Officer Mchugh Thomas S returned $2,108,400 worth of Ordinary Shares to the company (100,400 units at $21.00), closing all direct ownership in the company (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- Director Mccamish Mark Anthony returned $1,869,525 worth of Ordinary Shares to the company (89,025 units at $21.00), closing all direct ownership in the company (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- Director Glass Geoffrey Michael returned $3,506,664 worth of Ordinary Shares to the company (166,984 units at $21.00), closing all direct ownership in the company (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- Director Ende Eric J returned $4,618,005 worth of Ordinary Shares to the company (219,905 units at $21.00), closing all direct ownership in the company (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- Chief Executive Officer Divis Gregory J returned $4,643,205 worth of Ordinary Shares to the company (221,105 units at $21.00), closing all direct ownership in the company (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- Director Amin Naseem returned $462,000 worth of Ordinary Shares to the company (22,000 units at $21.00), closing all direct ownership in the company (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- Director Mccamish Mark Anthony gifted 67,025 units of Ordinary Shares and received a gift of 67,025 units of Ordinary Shares (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- SEC Form 4 filed by Director Palczuk Linda4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- SEC Form 4 filed by Director Glass Geoffrey Michael4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- Director Mccamish Mark Anthony was granted 11,000 units of Ordinary Shares, increasing direct ownership by 100% to 22,000 units (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- Director Palczuk Linda was granted 11,000 units of Ordinary Shares, increasing direct ownership by 16% to 78,900 units (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- Director Thornton Peter J. was granted 11,000 units of Ordinary Shares, increasing direct ownership by 11% to 115,055 units (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- Director Glass Geoffrey Michael was granted 11,000 units of Ordinary Shares, increasing direct ownership by 100% to 22,000 units (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- Director Ende Eric J was granted 11,000 units of Ordinary Shares, increasing direct ownership by 5% to 219,900 units (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- Director Amin Naseem was granted 11,000 units of Ordinary Shares, increasing direct ownership by 100% to 22,000 units (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- SEC Form 4 filed by Chief Operating Officer Rodriguez Susan4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- SEC Form 3 filed by new insider Rodriguez Susan3 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- Gen. Counsel & Corp. Secretary Seurer Jerad G. was granted 14,700 units of Ordinary Shares, increasing direct ownership by 167% to 23,495 units (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- Chief Financial Officer Mchugh Thomas S was granted 12,600 units of Ordinary Shares, increasing direct ownership by 14% to 100,400 units (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- Chief Executive Officer Divis Gregory J was granted 52,000 units of Ordinary Shares, increasing direct ownership by 33% to 211,100 units (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- SEC Form 4 filed by Director Palczuk Linda4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- Director Palczuk Linda bought $39,640 worth of Ordinary Shares (5,000 units at $7.93), increasing direct ownership by 8% to 67,900 units (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- Director Thornton Peter J. bought $80,450 worth of Ordinary Shares (10,000 units at $8.04), increasing direct ownership by 11% to 104,055 units (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- Director Ende Eric J bought $235,218 worth of Ordinary Shares (30,000 units at $7.84), increasing direct ownership by 17% to 208,900 units (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- Director Palczuk Linda gifted 3,500 units of Ordinary Shares, decreasing direct ownership by 5% to 62,900 units (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- SEC Form 4 filed by Director Palczuk Linda4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- Chief Financial Officer Mchugh Thomas S bought $24,019 worth of Ordinary Shares (2,300 units at $10.44), increasing direct ownership by 3% to 87,800 units (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- Chief Financial Officer Mchugh Thomas S bought $52,432 worth of Ordinary Shares (5,000 units at $10.49), increasing direct ownership by 6% to 85,500 units (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- Chief Executive Officer Divis Gregory J bought $99,707 worth of Ordinary Shares (10,000 units at $9.97) (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- Director Glass Geoffrey Michael bought $199,641 worth of Ordinary Shares (20,279 units at $9.84) (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- Director Palczuk Linda bought $30,568 worth of Ordinary Shares (3,000 units at $10.19), increasing direct ownership by 5% to 66,400 units (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- SEC Form 4 filed by Director Palczuk Linda4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- SEC Form 4 filed by Director Glass Geoffrey Michael4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- Director Palczuk Linda was granted 11,000 units of Ordinary Shares, increasing direct ownership by 21% to 63,400 units (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- Director Thornton Peter J. was granted 11,000 units of Ordinary Shares, increasing direct ownership by 13% to 94,055 units (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- Director Ende Eric J was granted 11,000 units of Ordinary Shares, increasing direct ownership by 7% to 178,900 units (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- Director Amin Naseem was granted 11,000 units of Ordinary Shares (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- Director Mccamish Mark Anthony was granted 11,000 units of Ordinary Shares (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- Director Glass Geoffrey Michael was granted 11,000 units of Ordinary Shares (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- SEC Form 4 filed by Amin Naseem4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- SEC Form 3 filed by new insider Amin Naseem3 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- New insider Seurer Jerad G. claimed ownership of 8,795 units of Ordinary Shares (SEC Form 3)3 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- SEC Form 4 filed by Kim Richard J4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- SEC Form 4 filed by Mchugh Thomas S4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- SEC Form 4 filed by Divis Gregory J4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- Mchugh Thomas S bought $29,000 worth of ADSs (2,000 units at $14.50), increasing direct ownership by 3% to 80,500 units (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- Mccamish Mark Anthony sold $1,089,750 worth of ADSs (75,000 units at $14.53) (SEC Form 4)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- SEC Form 4 filed by Palczuk Linda4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- SEC Form 4 filed by Glass Geoffrey Michael4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- SEC Form 4: Mccamish Mark Anthony sold $432,614 worth of ADSs (28,975 units at $14.93)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- SEC Form 4: Mchugh Thomas S bought $28,900 worth of ADSs (2,000 units at $14.45), increasing direct ownership by 3% to 78,500 units4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- SEC Form 4: Glass Geoffrey Michael bought $187,600 worth of ADSs (14,000 units at $13.40)4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- SEC Form 4: Divis Gregory J bought $131,997 worth of ADSs (10,000 units at $13.20), increasing direct ownership by 7% to 159,100 units4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
- SEC Form 4 filed by Ende Eric J4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)